SlideShare a Scribd company logo
1 of 16
PHARMACOECONOMICS
NEW PARADIGM
By:
Ms. Khan Dureshahwar M. Pharm (PhD)
Assistant Professor
Dept of Pharmacology
OUTCOMES
3-Dimensional Outcome Assessment
ECONOMIC
outcome
CLINICAL
outcome
HUMANISTIC
outcome
ECHO- Economic, Clinical, Humanistic Outcomes
Examples of Outcomes
Type of Outcome Examples
Economic Hospitalization,
Physician visits,
prescription drugs,
productivity
Clinical Symptoms, diagnosis,
Adverse events, Drug
interactions
Humanistic Quality of life,
satisfaction with
treatment, preference for
one treatment vs. another
The conceptual model: Economic, Clinical, and Humanistic Outcomes (ECHO) Model Source:
Adaption of a figure in an article by Kozma CM, Reeder CE, Schulz RM. Economic, clinical,
and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther.
1993;15(6):1121-32.
WHAT ARE POLICY-MAKERS TRYING TO DO?
 Assure access to medical care
 Control the rate of growth of expenditures for medical care
 Protect and improve the health of the population
 Achieve efficient use of health care resources
Some Specific Areas For
Collaboration Among Economists,
Physicians, and Policy-Makers
• Evaluation of benefits and costs of new
technologies
• Measurement of how incentives affect
the behavior of patients, physicians,
and hospital administrators
• Analysis of time trends and cross-
sectional differences in utilization of
medical care
• Analysis of time trends and cross-
sectional differences in health
• Monitoring results of demonstration
projects
• Keeping policy-makers from making
really big mistakes
• How egalitarian a system does society
want?
• How to find the right balance between
administrative control and the market?
• How to determine an appropriate number
and mix of health care personnel?
• How to finance health care expenditures?
• How to reimburse hospitals and physicians?
• How to deal with advances in medical
technology?
New Paradigms in Healthcare
• Changing the role of the patient -> first-class
actor in his healthcare process
• Patient empowerment : educated patient, able to
make informed decisions
• Continuity of care: informational, management,
relational continuity
• Team care: multidisciplinary and cross-
organizational
• Large spectrum of computer-based applications
Basic AdvancedIntermediate
Hospital Information Systems
Clinical Information
Systems
Chronic Disease
Public Health Surveillance
Electronic Health Records
Telemedicine
ELECTRONIC MEDICAL RECORDS - A NEW PARADIGM
MODULES
Out Patient Module
In Patient Module
Investigation Module
Pharmacy Module
Operation Theatre Module
Intensive Care Module
Discharge Module
Total Patient Module
Order Of Occurrence
Digital Healthcare Ecosystem
Reflection of the Healthcare Ecosystem
Pharmacoeconomics New Paradigm in Healthcare

More Related Content

What's hot

Phases 3,4 and 5 of clinical trials
Phases 3,4 and 5 of  clinical trialsPhases 3,4 and 5 of  clinical trials
Phases 3,4 and 5 of clinical trialsDrShrey Bhatia
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackpavithra vinayak
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimenPARUL UNIVERSITY
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introductionbiinoida
 
Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.pavithra vinayak
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxAmeena Kadar
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trialankit sharma
 
Designing of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameedDesigning of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameedRumana Hameed
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics academic
 
CYCLOSPORINE TDM: @ RxVichuZ!! ;)
CYCLOSPORINE TDM: @ RxVichuZ!! ;)CYCLOSPORINE TDM: @ RxVichuZ!! ;)
CYCLOSPORINE TDM: @ RxVichuZ!! ;)RxVichuZ
 
Inhibition and induction of drug metabolism @ RxVichuZ!! ;)
Inhibition and induction of drug metabolism @ RxVichuZ!! ;)Inhibition and induction of drug metabolism @ RxVichuZ!! ;)
Inhibition and induction of drug metabolism @ RxVichuZ!! ;)RxVichuZ
 
Introduction to Bayesian theory
Introduction to Bayesian theoryIntroduction to Bayesian theory
Introduction to Bayesian theoryKrishna Shriram.D
 
Ethical guidelines in clinical research @ RxVichuZ!!! ;)
Ethical guidelines in clinical research @ RxVichuZ!!! ;)Ethical guidelines in clinical research @ RxVichuZ!!! ;)
Ethical guidelines in clinical research @ RxVichuZ!!! ;)RxVichuZ
 

What's hot (20)

Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
Phases 3,4 and 5 of clinical trials
Phases 3,4 and 5 of  clinical trialsPhases 3,4 and 5 of  clinical trials
Phases 3,4 and 5 of clinical trials
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Phase 0 clinical trial
Phase 0 clinical trialPhase 0 clinical trial
Phase 0 clinical trial
 
Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.
 
Population pharamacokinetics
Population pharamacokineticsPopulation pharamacokinetics
Population pharamacokinetics
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
 
TDM of psychiatric drugs
TDM of psychiatric drugsTDM of psychiatric drugs
TDM of psychiatric drugs
 
Documentation clinical trial
Documentation clinical trialDocumentation clinical trial
Documentation clinical trial
 
Designing of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameedDesigning of clinical study protocol rumana hameed
Designing of clinical study protocol rumana hameed
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
CYCLOSPORINE TDM: @ RxVichuZ!! ;)
CYCLOSPORINE TDM: @ RxVichuZ!! ;)CYCLOSPORINE TDM: @ RxVichuZ!! ;)
CYCLOSPORINE TDM: @ RxVichuZ!! ;)
 
Inhibition and induction of drug metabolism @ RxVichuZ!! ;)
Inhibition and induction of drug metabolism @ RxVichuZ!! ;)Inhibition and induction of drug metabolism @ RxVichuZ!! ;)
Inhibition and induction of drug metabolism @ RxVichuZ!! ;)
 
Introduction to Bayesian theory
Introduction to Bayesian theoryIntroduction to Bayesian theory
Introduction to Bayesian theory
 
Ethical guidelines in clinical research @ RxVichuZ!!! ;)
Ethical guidelines in clinical research @ RxVichuZ!!! ;)Ethical guidelines in clinical research @ RxVichuZ!!! ;)
Ethical guidelines in clinical research @ RxVichuZ!!! ;)
 

Similar to Pharmacoeconomics New Paradigm in Healthcare

Health Economics In Clinical Trials - Pubrica
Health Economics In Clinical Trials  - PubricaHealth Economics In Clinical Trials  - Pubrica
Health Economics In Clinical Trials - Pubricapubrica101
 
Accounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxAccounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxnettletondevon
 
Fda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivFda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivNathan White, CPC
 
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docxtamicawaysmith
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
Electronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision MedicineElectronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision MedicineKent State University
 
Trends & Issue Medical surgical nsg.pptx
Trends & Issue Medical surgical nsg.pptxTrends & Issue Medical surgical nsg.pptx
Trends & Issue Medical surgical nsg.pptxkanwark781
 
Trends & Issue Medical Surgical Nursing,
Trends & Issue Medical Surgical Nursing,Trends & Issue Medical Surgical Nursing,
Trends & Issue Medical Surgical Nursing,GajeSingh9
 
Leveraging Anonymized Patient Level Data to Detect Hidden Market Potential
Leveraging Anonymized Patient Level Data to Detect Hidden Market PotentialLeveraging Anonymized Patient Level Data to Detect Hidden Market Potential
Leveraging Anonymized Patient Level Data to Detect Hidden Market PotentialCognizant
 
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULT...
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE  MULT...mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE  MULT...
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULT...Levi Shapiro
 
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαΗ συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαEvangelos Fragkoulis
 
Brad Doebbeling Conference Slides
Brad Doebbeling Conference SlidesBrad Doebbeling Conference Slides
Brad Doebbeling Conference SlidesShawnHoke
 
Marketing in hospitals
Marketing in hospitalsMarketing in hospitals
Marketing in hospitalsBakul Arora
 
Prescription auditing
Prescription auditingPrescription auditing
Prescription auditingSumit Kumar
 
Editorial Clinical pharmaceutical care and new technologies a synergy to high...
Editorial Clinical pharmaceutical care and new technologies a synergy to high...Editorial Clinical pharmaceutical care and new technologies a synergy to high...
Editorial Clinical pharmaceutical care and new technologies a synergy to high...M. Luisetto Pharm.D.Spec. Pharmacology
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond AndersonStarttech Ventures
 
Medication errors powerpoint
Medication errors powerpointMedication errors powerpoint
Medication errors powerpointlexie_daryan
 
How real data will transform predictive models
How real data will transform predictive modelsHow real data will transform predictive models
How real data will transform predictive modelsCharles DeShazer, M.D.
 

Similar to Pharmacoeconomics New Paradigm in Healthcare (20)

Health Economics In Clinical Trials - Pubrica
Health Economics In Clinical Trials  - PubricaHealth Economics In Clinical Trials  - Pubrica
Health Economics In Clinical Trials - Pubrica
 
Accounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxAccounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docx
 
Fda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In VentivFda Cms Summit Panel Preso In Ventiv
Fda Cms Summit Panel Preso In Ventiv
 
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
3KEY TERMS AND ACRONYMSAgency for Healthcare Research .docx
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicine
 
Electronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision MedicineElectronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision Medicine
 
Trends & Issue Medical surgical nsg.pptx
Trends & Issue Medical surgical nsg.pptxTrends & Issue Medical surgical nsg.pptx
Trends & Issue Medical surgical nsg.pptx
 
Trends & Issue Medical Surgical Nursing,
Trends & Issue Medical Surgical Nursing,Trends & Issue Medical Surgical Nursing,
Trends & Issue Medical Surgical Nursing,
 
Leveraging Anonymized Patient Level Data to Detect Hidden Market Potential
Leveraging Anonymized Patient Level Data to Detect Hidden Market PotentialLeveraging Anonymized Patient Level Data to Detect Hidden Market Potential
Leveraging Anonymized Patient Level Data to Detect Hidden Market Potential
 
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULT...
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE  MULT...mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE  MULT...
mHealth Israel_Gil Bashe- NAVIGATING THE MAZE- US PROVIDER SYSTEMS HAVE MULT...
 
MASTERS THESIS.DOC
MASTERS THESIS.DOCMASTERS THESIS.DOC
MASTERS THESIS.DOC
 
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη ΦαρμακοεπιδημιολογίαΗ συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
Η συνεισφορά της Γενικής Οικογενειακής Ιατρικής στη Φαρμακοεπιδημιολογία
 
Brad Doebbeling Conference Slides
Brad Doebbeling Conference SlidesBrad Doebbeling Conference Slides
Brad Doebbeling Conference Slides
 
Marketing in hospitals
Marketing in hospitalsMarketing in hospitals
Marketing in hospitals
 
Prescription auditing
Prescription auditingPrescription auditing
Prescription auditing
 
Editorial Clinical pharmaceutical care and new technologies a synergy to high...
Editorial Clinical pharmaceutical care and new technologies a synergy to high...Editorial Clinical pharmaceutical care and new technologies a synergy to high...
Editorial Clinical pharmaceutical care and new technologies a synergy to high...
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson
 
Dr hatem el bitar quality text (4)
Dr hatem el bitar quality text (4)Dr hatem el bitar quality text (4)
Dr hatem el bitar quality text (4)
 
Medication errors powerpoint
Medication errors powerpointMedication errors powerpoint
Medication errors powerpoint
 
How real data will transform predictive models
How real data will transform predictive modelsHow real data will transform predictive models
How real data will transform predictive models
 

More from Dureshahwar khan

ESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptx
ESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptxESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptx
ESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptxDureshahwar khan
 
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxTools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxDureshahwar khan
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxDureshahwar khan
 
ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...
ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...
ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...Dureshahwar khan
 
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptx
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptxWHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptx
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptxDureshahwar khan
 
Basic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Basic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxBasic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Basic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxDureshahwar khan
 

More from Dureshahwar khan (6)

ESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptx
ESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptxESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptx
ESTABLISHMENT OF PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance).pptx
 
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxTools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Tools used in Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptx
 
ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...
ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...
ADR Surveillance in Pharmacovigilance (Clinical Research & Pharmacovigilance)...
 
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptx
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptxWHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptx
WHO AND PHARMACOVIGILANCE (Clinical Research & Pharmacovigilance.pptx
 
Basic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Basic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptxBasic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
Basic aspects of Pharmacovigilance (Clinical Research & Pharmacovigilance).pptx
 

Recently uploaded

Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 

Recently uploaded (20)

Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 

Pharmacoeconomics New Paradigm in Healthcare

  • 1. PHARMACOECONOMICS NEW PARADIGM By: Ms. Khan Dureshahwar M. Pharm (PhD) Assistant Professor Dept of Pharmacology
  • 4. Examples of Outcomes Type of Outcome Examples Economic Hospitalization, Physician visits, prescription drugs, productivity Clinical Symptoms, diagnosis, Adverse events, Drug interactions Humanistic Quality of life, satisfaction with treatment, preference for one treatment vs. another
  • 5. The conceptual model: Economic, Clinical, and Humanistic Outcomes (ECHO) Model Source: Adaption of a figure in an article by Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther. 1993;15(6):1121-32.
  • 6. WHAT ARE POLICY-MAKERS TRYING TO DO?  Assure access to medical care  Control the rate of growth of expenditures for medical care  Protect and improve the health of the population  Achieve efficient use of health care resources
  • 7. Some Specific Areas For Collaboration Among Economists, Physicians, and Policy-Makers
  • 8. • Evaluation of benefits and costs of new technologies • Measurement of how incentives affect the behavior of patients, physicians, and hospital administrators • Analysis of time trends and cross- sectional differences in utilization of medical care
  • 9. • Analysis of time trends and cross- sectional differences in health • Monitoring results of demonstration projects • Keeping policy-makers from making really big mistakes
  • 10. • How egalitarian a system does society want? • How to find the right balance between administrative control and the market? • How to determine an appropriate number and mix of health care personnel? • How to finance health care expenditures? • How to reimburse hospitals and physicians? • How to deal with advances in medical technology?
  • 11. New Paradigms in Healthcare • Changing the role of the patient -> first-class actor in his healthcare process • Patient empowerment : educated patient, able to make informed decisions • Continuity of care: informational, management, relational continuity • Team care: multidisciplinary and cross- organizational
  • 12. • Large spectrum of computer-based applications Basic AdvancedIntermediate Hospital Information Systems Clinical Information Systems Chronic Disease Public Health Surveillance Electronic Health Records Telemedicine
  • 13. ELECTRONIC MEDICAL RECORDS - A NEW PARADIGM MODULES Out Patient Module In Patient Module Investigation Module Pharmacy Module Operation Theatre Module Intensive Care Module Discharge Module Total Patient Module Order Of Occurrence
  • 15. Reflection of the Healthcare Ecosystem